ALINE TAKEJIMA | Tissue engineering | Women Researcher Award

Posted on by Cell Biologist

Dr. ALINE TAKEJIMA | tissue engineering | Women Researcher Award

Dr. ALINE TAKEJIMA, pontificia universidade catolica do parana, Brazil

Dr. Aline Luri Takejima is a physician-scientist from Brazil, specializing in regenerative medicine and wound healing. She holds an MD and a PhD in Health Sciences from the Pontifical Catholic University of Paraná (PUCPR), where she currently conducts postdoctoral research. With a focus on biological therapies involving the amniotic membrane, Wharton’s jelly, and mononuclear stem cells, Dr. Takejima has published in multiple high-impact scientific journals. Her research aims to develop novel regenerative strategies to treat complex wounds and enhance tissue repair. As an active member of PUCPR’s Wound Healing Research Group and the Brazilian Society of Plastic Surgery, she combines scientific rigor with clinical insight to bridge bench-to-bedside innovation. Her academic contributions are guided by a translational approach, offering promising avenues for future clinical applications in tissue engineering.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Focused Research Excellence:
    Dr. Takejima’s work on biological scaffolds and stem cells in wound healing is both innovative and clinically relevant. Her studies using amniotic membrane, Wharton’s jelly, and bone marrow mononuclear cells show promising regenerative outcomes in preclinical models.

  2. Research Productivity:
    With 9 peer-reviewed journal articles in high-quality platforms (e.g., Biomedicines, Tissue Barriers, Annals of Biomedical Engineering), she demonstrates consistent academic output in her field.

  3. Translational Impact:
    Her research bridges basic science and clinical practice, aiming to provide regenerative solutions for patients with chronic wounds and cardiac damage.

  4. Collaborative Engagement:
    Active participation in a multidisciplinary wound healing research group, contributing to cross-functional scientific advancements.

  5. Recognition Potential:
    As a young, emerging woman researcher in biomedical sciences, she stands as a role model for future female scientists in Latin America and beyond.

🔧 Areas for Improvement:

  1. Intellectual Property & Innovation:
    No patents filed yet; transitioning her research into patentable therapies or commercial applications would increase its societal and economic impact.

  2. Leadership Roles:
    While active in research, taking on editorial or scientific leadership positions would enhance her academic visibility and influence.

  3. Internationalization:
    She would benefit from developing international collaborations or fellowships to diversify her research scope and increase global reach.

  4. Industry Engagement:
    Engaging in consultancy or biotech partnerships can further the translational impact of her regenerative strategies.

🎓 Education:

Dr. Takejima’s educational journey began with a Doctor of Medicine (MD) degree from the Pontifical Catholic University of Paraná (PUCPR), Brazil. Her passion for research led her to pursue a Doctorate (PhD) in Health Sciences/Medicine, also at PUCPR. Her doctoral thesis focused on the use of biologically active materials such as the amniotic membrane and stem cells to enhance wound healing. Throughout her academic training, she demonstrated a strong commitment to translational medicine by integrating basic science with clinical practice. During her PhD, she engaged in experimental models involving stem cell therapy and tissue engineering, which laid the groundwork for her current postdoctoral research. Her educational path reflects both depth and specialization in the biomedical sciences, particularly in regenerative medicine and cellular therapies.

💼 Experience:

Dr. Aline Takejima has over a decade of experience in medical and scientific fields, balancing her role as a physician with that of a postdoctoral researcher. Her clinical background informs her research, particularly in areas of wound healing and regenerative medicine. At PUCPR, she contributes to the Wound Healing Research Group, where she is involved in designing and conducting animal model studies to test the effects of biomaterials and stem cells. Her multidisciplinary research integrates immunology, histopathology, and molecular biology. With nine peer-reviewed publications and participation in collaborative research, she has become a respected contributor to the field. Though early in her research career, her trajectory shows a steady rise, marked by evidence-based outcomes and a commitment to innovation. Her goal is to bridge clinical challenges with regenerative solutions that can be implemented in real-world medical practice.

🔬 Research Focus:

Dr. Takejima’s research focuses on regenerative strategies for wound healing, utilizing biomaterials and stem cells. Her work primarily explores the application of amniotic membrane, Wharton’s jelly, and bone marrow-derived mononuclear stem cells in treating complex or chronic skin wounds. Using experimental models in rats and rabbits, she evaluates histological recovery, inflammation modulation, and tissue regeneration. A significant aspect of her research is understanding how these materials promote healing through paracrine effects rather than direct integration, offering a safer and scalable pathway to clinical application. Additionally, her work extends to cardiac and tracheal tissue repair, emphasizing the versatility of these regenerative approaches. The translational nature of her research bridges laboratory discoveries with potential bedside applications, positioning her at the forefront of cellular therapy and biomaterials science.

📚 Publications Top Notes:

  1. 🧠 Wharton’s Jelly Bioscaffolds Improve Cardiac Repair with Bone Marrow Mononuclear Stem Cells in Rats – Journal of Functional Biomaterials, 2025

  2. 🧫 The effects of decellularized amniotic membrane and Wharton’s jelly on the healing of experimental skin wounds in rats – Tissue Barriers, 2025

  3. ❤️ Bone-marrow mononuclear cells and acellular human amniotic membrane improve global cardiac function… – Anais da Academia Brasileira de Ciências, 2024

  4. 🫁 Tracheal regeneration with acellular human amniotic membrane and 15d-PGJ2 nanoparticles in rabbits – Anais da Academia Brasileira de Ciências, 2023

  5. 🧬 Acellular Biomaterials + Autologous Stem Cells Improve Wound Healing via Paracrine Effects – Biomedicines, 2023

  6. 💉 Decellularized Amniotic Membrane Solubilized with Hyaluronic Acid in Wound Healing – Annals of Biomedical Engineering, 2022

  7. 🧪 Role of Mononuclear Stem Cells and Decellularized Amniotic Membrane in Skin Wounds – Tissue Barriers, 2022

  8. 🏥 Trauma hepático: epidemiologia de cinco anos… – Revista do Colégio Brasileiro de Cirurgiões, 2008

🧾 Conclusion:

Dr. Aline Luri Takejima is an outstanding candidate for the Women Researcher Award. Her academic profile demonstrates a strong foundation in regenerative medicine with significant contributions to wound healing research. Her commitment to applying biological therapies in clinical contexts shows both depth and innovation. As a woman scientist in a competitive field, she exemplifies leadership, dedication, and potential. With further growth in global engagement and innovation strategy, Dr. Takejima is poised to become a future leader in regenerative biomedical research.

Yang Liu | Cell Migration Studies | Best Researcher Award

Posted on by Cell Biologist

Prof. Dr. Yang Liu | Cell Migration Studies | Best Researcher Award

Prof. Dr. Yang Liu, Taiyuan University of Technology Institute of Biomedical Engineering CHINA, China

Dr. Yang Liu is an Associate Professor at the Institute of Biomedical Engineering, Taiyuan University of Technology, China. Since joining in 2013, Dr. Liu has focused on biomechanics, particularly the mechanical mechanisms involved in skin tissue damage and healing processes during traumatic events like burns and radiotherapy. Her interdisciplinary work bridges molecular, cellular, and tissue-level studies to better understand the interplay between mechanical factors and skin regeneration. Her research also extends into the development and structural optimization of biomedical materials such as tissue-engineered skins and advanced dressings. Dr. Liu has led several research and teaching reform projects, obtained a patent transformation, and contributed to national and provincial-level scientific investigations. Her innovative work in tissue engineering and skin trauma treatment continues to contribute significantly to biomedical science and material engineering.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Specialized Expertise
    Dr. Liu focuses on biomechanics in disease development, particularly related to cutaneous trauma (e.g., burns, radiotherapy), a niche but critical area in biomedical engineering.

  2. Material Innovation
    Her work in developing tissue-engineered skin and antibacterial dressings demonstrates applied innovation with potential clinical relevance.

  3. Project Leadership
    Successfully led and participated in multiple competitive research projects funded by national and provincial bodies, indicating trust in her scientific vision and capabilities.

  4. Research Productivity
    Though early in recognition, Dr. Liu has already co-authored several peer-reviewed journal articles in reputable publications like Scientific Reports and Placenta, which reflect growing academic contribution.

  5. Translational Research
    Her involvement in a patent achievement transformation shows a commitment to moving research beyond the lab into real-world applications.

🔧 Areas for Improvement:

  1. Citation Impact and Indexing
    The provided articles currently have 0 citations, and there is no citation index or h-index reported. Increasing publication visibility and citation impact should be a future focus.

  2. Global Recognition and Collaboration
    There is no mention of international collaboration, editorial roles, or professional memberships, which would enhance credibility and reach.

  3. Documented Industry Linkages
    Despite some project engagement with enterprises, more evidence of sustained industry partnerships or commercialization success would strengthen the application.

  4. Books, Patents, and Conferences
    Absence of published books, patents in process, or keynote roles in international conferences limits the academic portfolio breadth.

🎓 Education:

Although specific degree details are not listed, Dr. Yang Liu has built a strong academic foundation that supports her expertise in biomedical engineering and biomechanics. Her academic journey is closely aligned with her professional role at Taiyuan University of Technology, which is known for its technical research capabilities. Dr. Liu’s knowledge spans skin tissue biology, mechanical trauma, and biomedical materials science, indicating a background that likely includes degrees in biomedical engineering, bioengineering, or a related field. Her educational experience has equipped her with the skills necessary to conduct high-level research in skin regeneration, materials science, and tissue biomechanics. Additionally, her active participation in national scientific projects and her leadership in academic innovation at the university level point to rigorous formal training and ongoing academic development.

🧪 Experience:

Dr. Yang Liu has over a decade of professional experience in biomedical research since joining the Taiyuan University of Technology in 2013. Her work has revolved around exploring the mechanical and biological factors involved in traumatic skin injury and healing. She has successfully led and contributed to multiple projects, including those funded by the National Natural Science Foundation of China and enterprise collaborations. In addition to her scientific contributions, she has also directed teaching reform projects and a patent transformation, highlighting her dual commitment to both research and education. Her experience includes a strong focus on interdisciplinary collaboration across biology, materials science, and mechanical engineering. This breadth of experience has allowed her to develop innovative biomedical materials, such as tissue-engineered skin and functional skin dressings, aimed at improving clinical treatment outcomes for burn injuries and other trauma-related skin conditions.

🔬 Research Focus:

Dr. Yang Liu’s research centers on the biomechanics of skin tissue damage and healing, with an emphasis on cutaneous trauma from burns and radiotherapy. Her work investigates how mechanical forces impact skin at multiple biological levels—molecular, cellular, tissue, and animal models. A major portion of her research explores biomedical material innovation, particularly tissue-engineered skin, skin dressings, and antibacterial materials. She is particularly focused on understanding how structural and mechanical properties of these materials can improve therapeutic outcomes. Dr. Liu also studies oxidative stress, cell migration, and protein responses under mechanical pressure, making her work crucial to trauma therapy and regenerative medicine. With a patent transformation and multiple research projects to her credit, her research is positioned at the intersection of engineering innovation and clinical application, aiming to reduce complications in skin trauma treatment and enhance recovery efficiency through scientifically engineered materials.

📚 Publications Top Notes:

  1. 🧴🧬 Preparation and characterization of nano-silver/graphene oxide antibacterial skin dressing – Scientific Reports, 2025

  2. 🔬⛽ Experimental study on liquid products and pore structure characteristics of anthracite saturated by supercritical CO₂ – Gas Science and Engineering, 2025

  3. 🧠💥 The regulatory role of the nuclear scaffold protein Emerin on the migration of amniotic epithelial cells and oxidative stress in a pressure environment – Placenta, 2025

  4. 🛠️🔥 Annealing Response of Cold-rolled Ti₂AlNb Based Alloy Foil in Different Phase Regions – Tezhong Zhuzao Ji Youse Hejin (Special Casting and Nonferrous Alloys), 2025

📝 Conclusion:

Dr. Yang Liu shows significant promise as a biomedical researcher, with a clear, focused research trajectory, practical outputs (materials for skin regeneration), and consistent project engagement at institutional and national levels. While her global visibility and citation metrics are currently limited, her research has high translational potential in trauma medicine and biomedical materials, making her a strong emerging contender for the Best Researcher Award—especially under a category recognizing early- to mid-career researchers with impactful applied science work.

Mahedi Hasan | Plasma Medicine | Young Researcher Award

Posted on by Cell Biologist

Mr. Mahedi Hasan | Plasma Medicine | Young Researcher Award

Mr. Mahedi Hasan, Shizuoka University, Japan

Mahedi Hasan is a promising Bangladeshi researcher with a strong academic and research foundation in genetic engineering and nanostructured optoelectronics. Currently pursuing his PhD at Shizuoka University, Japan, his work bridges plasma science with biomedical applications, focusing on cold atmospheric microplasma for drug delivery and cellular modulation. Previously, Mahedi completed his BS and MS in Genetic Engineering and Biotechnology from the University of Rajshahi with excellent academic distinction. He has published extensively in international peer-reviewed journals, collaborating with multinational research teams in Japan and Bangladesh. His passion lies in innovative, interdisciplinary approaches to solving complex biomedical problems, with a vision to improve targeted therapeutics. Mahedi has demonstrated remarkable dedication, from assisting in molecular biology labs to leading pioneering plasma-based biomedical research. With an emerging global presence and deep scientific curiosity, Mahedi Hasan is an ideal candidate for the Young Researcher Award.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Robust Academic Foundation

    • Strong academic performance in both undergraduate (CGPA 3.63) and postgraduate (CGPA 3.87) studies in Genetic Engineering & Biotechnology.

    • Currently pursuing a PhD in Optoelectronics and Nanostructure Science at a reputable Japanese institution (Shizuoka University), indicating a cross-disciplinary research approach.

  2. High-Impact Research Contributions

    • Authored 10+ peer-reviewed publications, several in Q1 journals, addressing cutting-edge topics such as cold atmospheric plasma (CAP), drug delivery, and cellular senescence.

    • Demonstrated innovation in plasma-assisted biomedical applications, including nose-to-brain delivery systems and BBB penetration strategies.

  3. International Collaboration and Experience

    • Collaborates with an international team across Bangladesh and Japan, engaging in complex projects with global relevance.

    • Ongoing research in Japan exposes him to high-end lab infrastructure and interdisciplinary training.

  4. Recognitions and Scholarships

    • Winner of the National Science and Technology (NST) Fellowship – 2019, a significant national-level endorsement of research potential.

    • Recipient of the Graduate Board Scholarship – 2019 for academic excellence.

  5. Consistent Research Focus

    • Maintains a clear research trajectory from plant plasma applications to nanotechnology and plasma-driven biomedical interventions, showcasing a deepening specialization.

🧩 Areas for Improvement:

  1. Independent Project Leadership

    • Most publications are collaborative; demonstrating leadership in principal investigator (PI)-style roles or initiating independent proposals would further establish his research autonomy.

  2. Wider Conference Participation

    • Engaging more frequently in international conferences and symposiums (oral/poster presentations) would enhance visibility and networking.

  3. Diversification of Funding Sources

    • Beyond national scholarships, pursuing international research fellowships (e.g., JSPS, DAAD, Marie Skłodowska-Curie) would show strategic initiative and grant-writing skills.

  4. Industrial/Clinical Relevance Expansion

    • Potential to link his plasma-based research with real-world medical or commercial applications through translational or industry-collaborative projects.

📘 Education:

Mahedi Hasan’s academic journey showcases consistent excellence. He is currently pursuing a Ph.D. in Optoelectronics and Nanostructure Science at Shizuoka University, Japan (2023–ongoing), where his research focuses on cold plasma-mediated drug delivery systems. He holds both Bachelor’s (2018) and Master’s (2019) degrees in Genetic Engineering and Biotechnology from the University of Rajshahi, Bangladesh. Despite delays in examination schedules, he graduated with distinction, securing a CGPA of 3.87/4.00 in MS and 3.63/4.00 in BSc. His academic records demonstrate a strong foundation in life sciences, biotechnology, and interdisciplinary research. Through his studies, he developed expertise in molecular biology, protein science, and advanced biomedical technologies. His transition into nanostructured optoelectronics further highlights his adaptability and commitment to advancing next-generation therapeutic technologies. Mahedi’s education reflects not only academic brilliance but also his progressive shift toward impactful, translational science.

🧪 Experience:

Mahedi Hasan has garnered substantial research experience across molecular biology and plasma-based therapeutics. He served as a Research Assistant at the

Apply now for the Plasma Medicine Research for Young Researcher Award—honoring early-career scientists advancing plasma technology in medicine. Open to researchers under 35. Submit your abstract and supporting documents today!

& Protein Science Lab in the Department of Genetic Engineering & Biotechnology, University of Rajshahi, from May 2019 to September 2023. His role included evaluating the effects of low-pressure dielectric barrier discharge (LPDBD) plasma on the growth, physiology, and nutritional properties of crops like wheat and maize. Prior to that, he completed a Research Internship in the same lab, where he explored the impact of LFGD plasma on agronomic and nutritional traits. His current Ph.D. research continues this trajectory, now exploring cold atmospheric microplasma for improved drug absorption across the blood-brain barrier and in cancer cells. Mahedi’s experience demonstrates a unique blend of plant and human model systems, bench-to-bedside translation, and strong interdisciplinary collaboration in both Bangladeshi and Japanese labs.

🏅 Awards and Honors:

Mahedi Hasan’s research potential has been recognized with several prestigious awards. In 2019, he received the National Science and Technology (NST) Fellowship from the Ministry of Science and Technology, Government of Bangladesh, a competitive award supporting emerging scientific talent. That same year, he was honored with the Graduate Board Scholarship by the University of Rajshahi, granted for his academic excellence during his Master’s studies. These accolades highlight his academic brilliance and commitment to impactful research. His continuous involvement in high-impact international collaborations and publications in reputable journals further solidify his reputation as a dedicated young scientist. As a Ph.D. candidate in Japan, he continues to contribute to frontier biomedical applications of microplasma technology. These honors, coupled with his impressive research output and global collaborations, make him an outstanding contender for any young researcher recognition.

🔬 Research Focus:

Mahedi Hasan’s research uniquely bridges biotechnology, plasma physics, and nanomedicine. His core focus is on the application of cold atmospheric microplasma in enhancing drug delivery, especially across complex barriers like the blood-brain barrier and into cancerous cells. His work explores microplasma-assisted nose-to-brain delivery systems, cellular senescence modulation, and targeted uptake of hydrophilic compounds. His research employs both cellular (in vitro) and animal (in vivo) models to study absorption efficiency, molecular interaction, and bioavailability of therapeutic agents. In his early work, he investigated plasma’s role in altering the physiology and nutritional value of crops. Now, through cutting-edge interdisciplinary collaborations at Shizuoka University, he is working at the frontier of plasma-assisted biomedical innovation, opening new doors for non-invasive drug delivery systems. This fusion of bioscience with physical sciences represents a novel, transformative approach, making his research both timely and globally significant.

📚 Publications Top Notes:

  1. 📄 Microplasma-Mediated Enhancement of FD-150 Uptake in HL-60 Cells

  2. 🧠 Absorption of FD-150 in Brain Endothelial Cells by Cold Atmospheric Microplasma

  3. 🧬 Exploring the Role of Microplasma for Controlling Cellular Senescence in Saccharomyces cerevisiae

  4. ⚡ Voltage Dependent Effect of Spiral Wound Plasma Discharge on DBC1.2 Cellular Integrity

  5. 🧪 Enhancing Galantamine Distribution in Rat Brain Using Microplasma-Assisted Nose-to-Brain Drug Delivery

  6. 🧫 Absorption of FD-150 into White Blood Cells by Microplasma

  7. 🚧 In Vitro Drug Delivery through the Blood–Brain Barrier Using Cold Atmospheric Plasma

  8. 🧼 Lipidomics of Microplasma-Irradiated Cells at Optimized Discharge Conditions for Absorption of High-Molecule Drug

  9. 🐍 Toxins Profiles and Histological Impact of Trimeresurus erythrurus Venom: In Vitro and In Vivo Study

  10. 🧯 Evaluation of Bungarus caeruleus Venom and Antivenom Efficacy Used in Bangladesh

📝 Conclusion:

Mahedi Hasan emerges as a highly promising young researcher with a multidisciplinary profile rooted in biotechnology, plasma science, and nanostructure-based drug delivery systems. His solid academic background, commendable publication record, and international research involvement make him a strong contender for the Young Researcher Award. While he could benefit from taking on greater research leadership and wider dissemination of his work, his achievements to date clearly indicate excellent potential for impactful scientific contributions in the coming years.

Marija Gjorgoska | Cancer Cell Biology | Best Researcher Award

Posted on by Cell Biologist

Mrs. Marija Gjorgoska | Cancer Cell Biology | Best Researcher Award

Mrs. Marija Gjorgoska | Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana | Slovenia

Marija Gjorgoska is a dedicated biomedical researcher and teaching assistant at the Faculty of Medicine, University of Ljubljana, Slovenia. With a strong background in biochemistry, molecular biology, and bioinformatics, she has contributed significantly to cancer research, focusing on steroid hormone signaling in gynecological cancers. Her scientific work combines analytical expertise in LC-MS/MS with a solid foundation in molecular biology and statistical analysis using R programming. Marija is passionate about advancing clinical diagnostics and cancer treatment through high-precision biomolecular profiling. Her academic journey reflects international exposure through internships in the UK and Macedonia. She is known for her collaborative spirit and commitment to scientific rigor, which has led to multiple high-impact publications. Marija continues to mentor students and contribute to the academic community through her teaching role, making her a rising figure in molecular oncology research.

publication profile:

scopus

Strengths:

  1. High Research Productivity 📈
    Marija Gjorgoska has authored or co-authored 10 peer-reviewed publications in high-impact journals such as Progress in Lipid Research (IF 14.0), Trends in Endocrinology and Metabolism (IF 11.4), and Cancers. Her work shows consistent scientific output, often with first or shared first authorship.

  2. Cutting-Edge Technical Expertise 🔬
    She demonstrates advanced proficiency in LC-MS/MS method development, multi-steroid profiling, and bioinformatics (R programming). This makes her an expert in translational hormone research and biomarker discovery.

  3. Clinical Relevance and Innovation ⚕️
    Her research addresses urgent clinical challenges like endometrial cancer diagnosis and ovarian cancer drug resistance, applying modern analytical techniques combined with machine learning, which positions her at the forefront of personalized medicine.

  4. Recognition and Collaboration 🤝
    She has been awarded prestigious grants (e.g., Society of Endocrinology, UK), collaborated internationally (UK, Macedonia), and contributes to academia as a teaching assistant—all signs of an emerging research leader.

  5. Interdisciplinary Impact 🌐
    Marija effectively integrates molecular biology, biochemistry, analytical chemistry, and computational biology—indicative of her versatility and broad scientific impact.

Areas for Improvement:

  1. Independent Research Leadership
    While she has made substantial contributions as a junior and co-investigator, future work could benefit from establishing herself as a principal investigator or project leader, including securing her own research funding.

  2. Diversification of Research Themes
    Her focus has been predominantly on hormone-related cancers. Expanding into other disease models or mechanisms could broaden her impact and create new collaborative opportunities.

  3. Public Engagement and Outreach
    Enhancing her visibility through conference presentations, science communication, or community health initiatives would further solidify her standing as a leader and advocate for biomedical research.

Education :

Marija Gjorgoska is currently enrolled in a doctoral program in Biomedicine, specializing in Biochemistry and Molecular Biology at the University of Ljubljana. Her academic foundation includes a Master’s degree in Molecular Biology (2018–2021) from the same university, completed with an outstanding GPA of 9.52/10. She also gained international experience through a short-term internship at the University of Birmingham, UK, in 2023, focusing on advanced LC-MS/MS techniques for clinical sample analysis. Earlier in her academic career, she completed a long-term internship at the Research Center for Genetic Engineering and Biotechnology in Skopje, Macedonia (2017), where she worked on genetic diagnostics involving haemoglobinopathies, HPV, HBV, and HCV detection. Her education has consistently emphasized both theoretical knowledge and hands-on laboratory skills, particularly in analytical chemistry, molecular biology, and bioinformatics, all of which shape her current research endeavors in cancer diagnostics and hormonal regulation.

Experience:

Marija Gjorgoska has been actively engaged in research since 2020 as a Research Assistant at the Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana. Her core responsibilities include developing and validating LC-MS/MS analytical methods, conducting proteomic and genetic analyses of cancer tissues, and performing bioinformatic evaluations using R programming. In October 2024, she also began serving as a Teaching Assistant for the course “Principles of Biochemistry,” demonstrating her commitment to education and mentorship. Marija’s prior internships have equipped her with valuable skills in prenatal and infectious disease diagnostics. Her research contributions span experimental planning, scientific writing, and instrument maintenance, establishing her as a versatile scientist. Her collaborative projects with international researchers and clinicians further underline her strength in translational biomedical research. This combination of teaching, laboratory, and analytical expertise supports her growing influence in molecular oncology.

Awards and Honors:

Marija Gjorgoska has been recognized for both academic and research excellence. In 2023, she was awarded the Practical Skills Grant by the Society of Endocrinology, UK, enabling her to undergo advanced training in LC-MS/MS at the University of Birmingham. Earlier, in 2021, she received the Krka Recognition with Special Praise for her Master’s thesis, highlighting her early promise as a researcher in molecular biology. Her scientific publications have appeared in top-tier journals such as Progress in Lipid Research and Trends in Endocrinology and Metabolism, some with impact factors exceeding 14.0. Notably, she earned shared first co-authorship in Methods in Enzymology for her work on enzymatic assay development. These accolades reflect her technical excellence, originality, and scientific contributions in the field of steroid metabolism and gynecological cancers. Marija’s achievements distinguish her as a young researcher with significant impact and high potential for further contributions to science and medicine.

Research Focus :

Marija Gjorgoska’s research focuses on the role of steroid hormones in the development and progression of gynecological cancers, particularly endometrial and ovarian cancers. Her work integrates analytical chemistry (LC-MS/MS), bioinformatics, and molecular biology to uncover diagnostic and prognostic biomarkers. She has developed multi-steroid profiling techniques to differentiate between normal and cancerous tissues, aiding early diagnosis. Marija’s studies also address the pre-receptor regulation of androgenic and estrogenic hormones, exploring their signaling dynamics at the tissue level. Using tools such as Mendelian randomization, she investigates genetic influences on hormone-related disease risk. Her interdisciplinary approach combines advanced mass spectrometry, statistical modeling, and clinical collaboration to translate bench science into meaningful medical applications. Through high-impact publications, she contributes to understanding hormone metabolism in cancer microenvironments, with the goal of informing targeted therapies and overcoming drug resistance. Her work is critical for advancing personalized medicine in hormone-driven malignancies.

Publications Top Notes:

  1. 📘 From fallopian tube epithelium to high-grade serous ovarian cancer: A single-cell resolution review of sex steroid hormone signaling – Progress in Lipid Research, 2024

  2. 📘 Integration of androgen hormones in endometrial cancer biology – Trends in Endocrinology and Metabolism, 2022

  3. 📘 Steroid sulfatase and sulfotransferases in gynecological cancers: current status and perspectives – Essays in Biochemistry, 2024

  4. 📘 Estrogens and the Schrödinger’s cat in the ovarian tumor microenvironment – Cancers, 2021

  5. 📘 Multi-Steroid Profiling and Machine Learning Reveal Androgens as Biomarkers for Endometrial Cancer – Cancers, 2025

  6. 📘 Simultaneous measurement of 17 endogenous steroid hormones by LC-MS/MS – J. of Steroid Biochemistry and Molecular Biology, 2024

  7. 📘 11-oxyandrogens in normal vs. cancerous endometrium – Frontiers in Endocrinology, 2024

  8. 📘 Targeting estrogen metabolism to overcome platinum resistance in ovarian cancer – Biomedicine & Pharmacotherapy, 2024

  9. 📘 Effect of androgens on risk of endometriosis sub-phenotypes and ovarian neoplasms – J. of Steroid Biochemistry and Molecular Biology, 2024

  10. 📘 Enzymatic assays for 17β-HSD types 1 and 2 using mass spectrometry – Methods in Enzymology, 2023

Conclusion:

Marija Gjorgoska is a highly promising early-career researcher with a strong and growing international publication record, deep technical expertise in analytical biochemistry, and a clear focus on clinically relevant research. Her integration of hormonal pathway analysis with state-of-the-art analytical methods has already contributed valuable insights to the field of gynecological oncology. She has the academic rigor, curiosity, and collaborative drive essential for impactful science.

In my opinion, she is a highly suitable candidate for the Best Researcher Award. Continued mentorship and support toward independent research leadership will elevate her even further in the years to come.

Madeha Awad | Intracellular Transport Systems | Best Researcher Award

Posted on by Cell Biologist

Assoc. Prof. Dr. Madeha Awad | Intracellular Transport Systems | Best Researcher Award

Assoc. Prof. Dr. Madeha Awad, Sohag university, Egypt

Dr. Madeha Ahmed Aboelfadl Awad is an accomplished Associate Professor in the Physics Department, Faculty of Science, Sohag University, Egypt. Born on January 27, 1979, she has established herself as a leading researcher in the field of nanomaterials physics, with a focus on the synthesis and characterization of metal, metal oxide, and oxysulfide nanostructures. Fluent in Arabic, English, and French, Dr. Awad has contributed extensively to sustainable material applications, including photocatalysis, photodetectors, and smart coatings. Her passion for scientific inquiry and dedication to environmental and energy-related innovations have positioned her as a significant academic voice in Egypt and internationally. Married and residing in Sohag, she continues to inspire through both her teaching and prolific research publications, contributing to over 10 international journal articles and conference presentations. Dr. Awad’s interdisciplinary approach bridges materials science with real-world industrial and environmental applications.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Innovative Research Focus:
    Dr. Awad has demonstrated consistent innovation in synthesizing and characterizing advanced nanostructured systems (metal oxides, oxysulfides, and thin films), with real-world applications in environmental remediation, energy conversion, and optoelectronics.

  2. Publication Record:
    She has published 10+ articles in reputable international journals such as Physica Scripta and Journal of Materials Science: Materials in Electronics. Many of these works address pressing global challenges, including pollution control, clean energy, and smart coatings.

  3. Multidisciplinary Impact:
    Her work intersects physics, materials science, and environmental engineering, creating sustainable technologies like photocatalysts, hydrogen generation systems, and photodetectors.

  4. Active Conference Participation:
    Dr. Awad has presented at national and international scientific conferences, sharing her findings on SnO₂ thin films and transparent conductors, reflecting leadership in academic dissemination.

  5. Academic Development:
    She has completed multiple training courses in competitive research, digital transformation, and teaching methodologies, ensuring continuous growth and contribution to higher education quality.

🧩 Areas for Improvement:

  1. International Collaborations:
    While Dr. Awad is actively publishing, there is potential for expanding collaborations with global research institutes and industrial sectors to enhance the scope and visibility of her work.

  2. Research Funding Diversification:
    Engaging in international grant applications or large-scale collaborative projects would further strengthen her research sustainability and resource access.

  3. Visibility in High-Impact Conferences:
    Increasing participation in high-impact global conferences or symposiums (e.g., MRS, APS) could amplify her academic footprint and foster more research exchange.

🎓 Education:

Dr. Awad earned her B.Sc. in Physics with a very good degree from Sohag University in 2003. She pursued her M.Sc. in Solid State Physics (2008), focusing on the structural, electrical, and optical properties of Sn-Sb-Se compounds. In 2015, she received her Ph.D. in Nanomaterials Physics for her pioneering work on ZnO-based nanomaterials. Her Ph.D. research emphasized growth and characterization techniques vital for optoelectronic applications. In October 2020, she became an Associate Professor, having specialized in the synthesis and analysis of nanostructured systems, including metal oxides and oxysulfides, with targeted industrial uses. Her academic path reflects a deep commitment to solid-state physics, materials engineering, and nanotechnology. She has also enhanced her academic competencies with digital transformation, student assessment, and competitive research training, aligning her education with modern interdisciplinary needs and research innovations.

🧪 Professional Experience:

Dr. Awad began her academic journey as an Assistant Lecturer in 2013 at Sohag University’s Physics Department. Following the completion of her Ph.D. in 2015, she was promoted to Lecturer, contributing to undergraduate and postgraduate instruction while intensifying her research. In 2020, she was appointed Associate Professor in Materials Science. Over the years, Dr. Awad has participated in international conferences, served as a research mentor, and collaborated with national and international scholars. Her expertise in synthesizing thin films and evaluating their optical, structural, and electrical characteristics has enabled her to lead multiple applied research projects. In addition to teaching and supervision, she has completed various training programs on student assessment, digital transformation, and competitive research funding. Her holistic academic profile blends high-impact research with educational excellence, making her a valuable contributor to Egypt’s scientific and academic landscape.

🔬 Research Focus:

Dr. Madeha Awad’s research focuses on the synthesis, characterization, and application of nanostructured materials, particularly metal and metal oxide thin films. Her work addresses real-world challenges through environmentally friendly solutions such as photocatalysis for pollutant degradation, hydrogen generation from seawater, and smart coatings for self-cleaning surfaces. She is also active in developing photodetectors for environmental sensing. Her interdisciplinary approach integrates solid-state physics, material science, and environmental engineering. Her recent projects involve advanced nanocomposites like In2O3/CuO and TiO2-based systems, with optimized optoelectronic and wettability properties for diverse industrial applications. By modifying surface and structural properties of nano-films, Dr. Awad aims to enhance energy efficiency, sustainability, and environmental remediation technologies. She is a strong advocate for applied research and often collaborates on global research initiatives that promote clean energy and green technologies. Her vision merges innovation with impact.

📚 Publications Top Notes:

  1. 🔬 Photocatalytic characteristics of indium oxide, copper oxide and indium oxide/copper oxide thin films on plastic waste substrates for organic pollutants degradation

  2. 🔍 Influence of oxygen flow rates on the optoelectronic properties SnO2 thin films

  3. 🌿 A comparison between the effect of zinc oxide and zinc oxide nanoparticles on the growth and metabolic processes of Cosmarium sp

  4. 🌞 Highly sensitive TiO2 based photodetector for environmental sensing applications

  5. 🔦 Optoelectronic characteristics of In2O3/CuO thin films for enhanced visible-light photodetector

  6. 🧼 Photocatalysis, wettability and optical properties of N-doped Cu2O/CuO thin films for smart coating applications

  7. 💧 Surface wettability and photocatalytic activities of ZrOxNy/Au/TeO2 trilayers for antifogging coatings

  8. ⚡ Some characteristics of Cu/Cu2O/CuO nanostructure heterojunctions and their applications in hydrogen generation from seawater

  9. 🌐 WNxOy prepared by oxidation of tungsten nitride as alternative photocatalyst to N-doped WO3

📝 Conclusion:

Dr. Madeha Ahmed Aboelfadl Awad exemplifies the qualities of a modern researcher who blends academic rigor with real-world impact. Her research in nanomaterials for environmental and energy applications is both timely and significant. With a strong foundation in materials science and a clear trajectory of impactful publications, she is an excellent candidate for the Best Researcher Award.

Prity Yadav | Cell Death Pathway | Best Researcher Award

Posted on by Cell Biologist

Ms. Prity Yadav | Cell Death Pathway | Best Researcher Award

Ms. Prity Yadav, UNIVERSITY OF RAJASTHAN, JAIPUR, India

Prity Yadav is a dedicated research scholar at the Department of Zoology, University of Rajasthan, Jaipur, India. Under the guidance of Prof. P.C. Mali, she is pursuing a PhD focused on nanotechnology and reproductive biomedicine. With a strong academic foundation including an M.Sc. in Zoology and CSIR-NET-JRF qualification, she currently receives the Senior Research Fellowship (SRF) from CSIR, Delhi. Her interdisciplinary research combines herbal medicine and nanoscience to develop eco-friendly contraceptive strategies, aiming to revolutionize non-hormonal fertility control. Prity has published 11 research papers in reputed journals indexed in SCI and Scopus, and actively contributes to the scientific community through her work. A member of the Indian Science Congress Association, she is passionate about public health, sustainability, and the responsible use of nanobiotechnology for population control and reproductive health. Her work holds significant promise for advancing global reproductive healthcare through innovative, natural, and non-invasive solutions.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Focused and Impactful Research Area
    Prity Yadav’s interdisciplinary research on nanotechnology and reproductive biomedicine is both relevant and innovative, especially in addressing global concerns like non-hormonal contraception, male fertility regulation, and eco-friendly biomedical alternatives.

  2. Consistent Publication Record
    With 11 publications in reputed SCI and Scopus-indexed journals, her research contributions are well-documented and consistently recognized in the academic community.

  3. Research Innovation
    Her work in green synthesis of silver nanoparticles using medicinal plant extracts for antifertility treatments reflects high originality and societal relevance.

  4. Academic Excellence
    She has cleared CSIR-NET-JRF and is currently receiving SRF from CSIR, showing national-level academic competitiveness.

  5. Sustainability and Public Health Focus
    Her projects promote natural, sustainable alternatives to conventional fertility control methods, aligning with public health policy and eco-conscious innovation.

  6. Active Membership in Scientific Community
    Her involvement in organizations such as The Indian Science Congress Association supports her engagement in broader scientific discourse.

🔧 Areas for Improvement:

  1. International Collaborations & Exposure
    Participation in international research collaborations, conferences, or exchange programs would further enrich her global perspective and strengthen her research profile.

  2. Patent Filing and Intellectual Property
    Considering the novelty of her nanoformulations, pursuing patents could enhance the impact and translational value of her work.

  3. Industry Engagement
    Involvement in consultancy or industry-based projects would bridge the gap between lab research and real-world application.

  4. Editorial and Peer Review Roles
    Taking on editorial responsibilities or peer-review contributions would boost her academic service profile.

🎓 Education:

Prity Yadav has a solid academic background in life sciences, specializing in Zoology. She completed her Master of Science (M.Sc.) in Zoology with distinction, focusing on reproductive physiology and applied biology. Demonstrating her academic excellence, she cleared the highly competitive CSIR-NET-JRF examination, qualifying for Junior Research Fellowship and later advancing to Senior Research Fellowship (SRF) funded by CSIR, New Delhi. She is currently enrolled in the PhD program at the University of Rajasthan, Jaipur, under the supervision of Prof. P.C. Mali in the Department of Zoology. Her academic path reflects a consistent focus on animal biology, toxicology, and molecular studies related to fertility and reproduction. Her strong theoretical knowledge, combined with hands-on laboratory training in nanoscience and biomedical research, sets a solid foundation for her innovative research. Prity’s education is a blend of traditional life sciences and modern interdisciplinary tools like nanotechnology and phytomedicine.

🧪 Experience:

Prity Yadav has accumulated significant research experience during her doctoral studies at the University of Rajasthan. With over four years of hands-on laboratory work, she has become proficient in nanoparticle synthesis, in vivo animal experimentation, biochemical analysis, and histopathological techniques. Her research focuses on developing green-synthesized silver nanoparticles using herbal extracts and evaluating their antifertility effects in male rodents. She has co-authored 11 publications in reputable journals and collaborated with fellow researchers on interdisciplinary projects involving herbal pharmacology, nanomedicine, and reproductive biology. While she has no direct industry consultancy experience, her academic research aligns closely with pharmaceutical applications. She frequently presents her findings in national and international conferences and is an active member of the Indian Science Congress Association. Prity’s experience highlights her commitment to scientific rigor, ethical research practices, and a vision for creating sustainable healthcare solutions through biocompatible nanotechnologies.

🔬 Research Focus:

Prity Yadav’s research lies at the intersection of nanotechnology and reproductive biomedicine, with an emphasis on developing herbal-based, non-hormonal antifertility agents. Her work explores the green synthesis of silver nanoparticles using medicinal plant extracts, aiming to enhance bioavailability and targeted delivery of active phytoconstituents. The ultimate goal of her research is to create eco-friendly, reversible male contraceptive methods with minimal side effects. She focuses on evaluating the impact of these nanoparticles on male reproductive systems through in vivo studies using rodent models. Her findings contribute to a deeper understanding of reproductive toxicity, oxidative stress, and fertility regulation mechanisms. This research addresses global challenges such as overpopulation and limited access to safe male contraceptives. Prity’s interdisciplinary approach supports sustainable healthcare by integrating traditional herbal knowledge with modern nanoscience, opening new avenues in contraceptive technology and public health policy.

📚 Publications Top Notes: 

  1. 🌿🔬 Herbal Nanoparticles to Control Fertility and Regulation: A Review

  2. 🧫🔥 Testicular Inflammation in Male Reproductive System

  3. 🍃🧪 Assessment of the Antifertility Potential of Silver Nanoparticles Synthesized Using Pongamia pinnata Leaf Extract in Male Wistar Rats

  4. 🌱📖 Medicinal Plants Potentials of Fertility Control, Antioxidant and Antimicrobial Activities: A Review

  5. 🧬🌿 Potential Antifertility and Antimicrobial Activities of Plants Used in Traditional Medicines: A Review

  6. 💊🦠 Cassia auriculata-Based Silver Nanoparticles: A Novel Approach to Combat Bacterial Infections

  7. 🌾🧠 A Review on Potential Antioxidant, Neuroprotective and Antidepressant Activities of Herbal Medicinal Plants

  8. ⚗️🧍‍♂️ Effects of Silver Nanoparticles of Putranjiva roxburghii on Reproductive Organs in Male Albino Rats

  9. 🌳🧬 Exploring the Impacts of Tecomella undulata Mediated Silver Nanoparticles on Male Rats Fertility and Reproductive Health

  10. 🍀🧫 An In Vitro Antioxidant Potential Analysis of Herbal Silver Nanoparticles Synthesized from Methanolic Leaf Extract of Cassia siamea

🧾 Conclusion:

Based on her scientific contributions, innovative research, and academic merit, Prity Yadav is a highly suitable candidate for the Best Researcher Award. Her work presents a unique and impactful solution to pressing challenges in public health and reproductive medicine. With scope for further growth in collaborative and translational domains, she stands out as a rising researcher making meaningful advances in her field.

Tao Liang | Cell Death Pathway | Best Researcher Award

Posted on by Cell Biologist

Mr. Tao Liang | Cell Death Pathway | Best Researcher Award

Mr. Tao Liang, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, China

Dr. Tao Liang is an accomplished medicinal chemist with deep expertise in small molecule drug design, synthesis, and pharmacological evaluation. Originating from Dancheng County, Henan Province, and currently residing in Wuhu City, Anhui Province, Dr. Liang is an Assistant Researcher at The Second Affiliated Hospital of Wannan Medical College. He earned his Doctor of Medicine from Shandong University, a leading institution under China’s “Double First-Class” initiative. With over 7 first-author SCI publications and multiple national invention patents, his research significantly contributes to targeted cancer therapies, especially involving HDAC6-selective inhibitors and Bax agonists. He has successfully led key projects funded by the Anhui Provincial Government and participated in prestigious National Natural Science Foundation of China projects. Known for both scientific depth and innovation, Dr. Liang has been recognized with national-level scholarships and university-wide honors for outstanding research achievements and academic excellence.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. High-Impact Publications

    • Authored 7 first-author SCI papers, including publications in top-tier journals like Acta Pharm Sin B (IF 14.907) and J Med Chem (IF 8.039).

    • Published extensively on HDAC6 isoform-selective inhibitors and apoptosis-targeting small molecules, a niche and cutting-edge domain in anticancer drug research.

  2. Research Leadership & Innovation

    • Serves as Principal Investigator for two key provincial research projects focusing on selective cancer therapies.

    • Demonstrated innovation in designing dual-target inhibitors (MMP/HDAC) and novel Bax agonists.

  3. National-Level Collaborations

    • Participated in major National Natural Science Foundation of China projects (5 total), totaling over RMB 2 million in funding.

    • Engaged with multidisciplinary teams and key opinion leaders, including renowned researchers such as Prof. Hao Fang and Prof. Xuben Hou.

  4. Academic Recognition

    • Winner of prestigious honors such as the National Scholarship, Outstanding Doctoral Graduate, and guest speaker at elite academic forums.

    • Recipient of 15+ national and university-level awards, including innovation prizes and scholarships.

  5. Patent Contributions

    • Holds 4 national invention patents, reflecting translational potential and real-world application of his research outputs.

🔧 Areas for Improvement:

  1. International Visibility & Collaboration

    • Current research impact is primarily within domestic circles (China). Engaging in cc, postdoctoral exchanges, or publishing with international co-authors would elevate recognition.

  2. Clinical Translation Pipeline

    • Despite strong preclinical development, there is no direct evidence of transition to clinical trials or industrial commercialization. Partnering with biotech/pharma could increase translational outcomes.

  3. Leadership Beyond Research

    • As an early-career researcher, administrative leadership (e.g., lab director, national committee memberships) may still be developing. Building a research group or mentoring PhD students would strengthen this.

  4. Interdisciplinary Expansion

    • Expertise is strong in medicinal chemistry, but cross-disciplinary projects involving AI/drug discovery, systems biology, or clinical oncology could broaden the impact.

🎓 Education:

Dr. Tao Liang received his Bachelor of Science in Pharmacy from Shandong University (2013.9–2017.6), one of China’s elite institutions under the National “985 Project” and “Double First-Class” initiative. Continuing at the same university, he pursued a Master’s and Ph.D. in Medicinal Chemistry, earning a Doctor of Medicine degree in 2022. Shandong University, renowned for its Ministry of Education Class A-rated disciplines, provided Dr. Liang with a rigorous scientific environment and access to state-of-the-art research facilities. During his academic training, he developed a strong foundation in chemical biology, natural product synthesis, and drug development. His educational journey has been marked by consistent excellence, earning him accolades like National Scholarships and Outstanding Graduate awards. His academic credentials and extensive research during his Ph.D. have positioned him as a leading young researcher in the field of medicinal chemistry in China.

💼 Work Experience:

Since August 2022, Dr. Tao Liang has been serving as an Assistant Researcher at The Second Affiliated Hospital of Wannan Medical College. His research focuses on the structural design, chemical synthesis, and pharmacological activity evaluation of small molecule drugs, particularly targeting HDAC isoforms and apoptotic regulators like Bax. He currently leads two key projects: one on HDAC6-selective inhibitors and another on Bax agonists for cervical cancer therapy, funded by the Anhui Provincial Higher Education and Health Commission respectively. Previously, he participated in several high-impact national research projects, including two funded by the National Natural Science Foundation of China, focusing on anti-cancer drug discovery. His roles have involved both independent project leadership and critical collaboration within multidisciplinary teams. Dr. Liang’s work experience showcases his capabilities in translational medicinal chemistry research and positions him as a promising talent in pharmaceutical innovation.

🏆 Awards and Honors:

Dr. Tao Liang has received more than a dozen honors for his outstanding academic and research contributions. These include the prestigious National Scholarship (2021), Outstanding Doctoral Graduate of Shandong University (2022), and multiple first-class scholarships throughout his postgraduate studies. He was a special guest speaker at prominent forums like the “Haiyou Doctoral Forum” and “Lao Xu Talks about High Strategies.” His undergraduate years were equally distinguished, earning the first prize in the ‘Challenge Cup’ and honors like “Outstanding Graduate” and “Excellent Communist Youth League Member”. His early career was also decorated with international recognitions such as the First Prize for Innovation Results at the World University Students’ Pharmaceutical Garden Forum. These awards highlight both his academic brilliance and commitment to scientific advancement, affirming his eligibility and strength as a nominee for the Best Researcher Award.

🔬 Research Focus:

Dr. Tao Liang’s research centers on the design, synthesis, and biological evaluation of small molecule inhibitors with a primary focus on histone deacetylase 6 (HDAC6) isoform-selective inhibitors and Bax agonists for cancer therapy. His work integrates computational modeling, medicinal chemistry, and pharmacodynamics to create targeted therapies aimed at epigenetic modulation and apoptosis induction in cancer cells. He has actively contributed to national-level projects exploring dual-target inhibitors (MMP/HDAC) and small molecule interventions for Mcl-1 and striatal enriched tyrosine phosphatase (STEP) targets. Dr. Liang is particularly recognized for his innovation in optimizing chemical scaffolds for selective inhibition and minimizing off-target effects. Through collaborative and independent research, he aims to address challenges in chemotherapeutic resistance and toxicity. His scientific pursuits align with current global trends in precision oncology, making significant strides in targeted therapy development and laying a foundation for future clinical translation.

📚 Publications Top Notes:

  1. 📘 Design, synthesis and evaluation of structural optimization derived HDAC6 isoform-selective inhibitor – Bioorganic Chemistry, 2025

  2. 📗 Targeting histone deacetylases for cancer therapy: Trends and challenges – Acta Pharmaceutica Sinica B, 2023

  3. 📙 Potential applications of BPFP1 in Bcl-2 protein quantification, carcinoma cell visualization, cell sorting and early cancer diagnosis – European Journal of Medicinal Chemistry, 2021

  4. 📕 Design, synthesis and biological evaluation of 3,4-disubstituted-imidazolidine-2,5-dione derivatives as HDAC6 selective inhibitors – European Journal of Medicinal Chemistry, 2021

  5. 📘 Recent Development of Novel HDAC6 Isoform-selective Inhibitors – Current Medicinal Chemistry, 2021

  6. 📗 HDAC–Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells – Journal of Medicinal Chemistry, 2020

  7. 📙 Design, Synthesis, and Biological Evaluation of 2,4-Imidazolinedione Derivatives as HDAC6 Isoform-Selective Inhibitors – ACS Medicinal Chemistry Letters, 2019

  8. 📕 Synthesis and Antiproliferative Activity of Thiadiazole Peptidomimetic Derivatives – Chinese Journal of Organic Chemistry, 2016

🧾 Conclusion:

Dr. Tao Liang is highly suitable for the Best Researcher Award, especially in the early- to mid-career researcher category. His extensive publication record, innovative medicinal chemistry work, leadership in funded projects, and impressive academic recognitions make him an exemplary candidate.

minghe luo | Microbial Cell Biology | Best Researcher Award

Posted on by Cell Biologist

Mr. minghe luo | Microbial Cell Biology | Best Researcher Award

Mr. minghe luo , Chongqing University of Technology , China

Dr. Minghe Luo, born in April 1984, is an accomplished pharmaceutical scientist and Associate Professor at Chongqing University of Technology. Specializing in natural product biosynthesis, he has made significant contributions to the discovery of novel antibiotics and the mechanistic understanding of biosynthetic pathways from marine microorganisms. His academic journey has taken him through respected institutions including Wuhan University and Southwest University, with extensive research training at the South China Sea Institute of Oceanology. Known for his collaborative spirit and deep expertise in medicinal chemistry, Dr. Luo has authored numerous impactful publications in journals like Angewandte Chemie and Organic Letters. His work not only advances scientific knowledge but also offers practical implications for antibiotic development. A dedicated educator and researcher, Dr. Luo continues to explore microbial biosynthetic machinery, aiming to discover new therapeutics for drug-resistant infections.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Depth of Expertise:
    Dr. Luo has solid academic foundations with a PhD in Pharmacy and a Master’s in Medicinal Chemistry of Natural Products. His specialty in natural products biosynthesis—particularly from marine microorganisms—positions him uniquely in pharmaceutical research.

  2. Research Output & Impact:
    He has authored over 15 research papers in high-impact journals such as Angewandte Chemie, Organic Letters, Chemical Engineering Journal, and Journal of Natural Products. His work tackles urgent global needs, like antibiotic resistance, with research on compounds targeting MRSA and other drug-resistant pathogens.

  3. Innovation in Biosynthesis:
    His research on trans-AT polyketide synthases, novel biosynthetic pathways, and genome mining for cryptic natural products exemplifies forward-thinking, interdisciplinary science.

  4. Independent Research and Teaching:
    As an Associate Professor, he leads independent projects while teaching and mentoring students—demonstrating both leadership and academic service.

  5. Collaboration:
    His co-authored papers reflect strong collaborative ties, including with international researchers like Prof. Jeroen Dickschat (Germany), a mark of scientific credibility and connectivity.

⚠️ Areas for Improvement:

  1. Patent/Translational Outputs:
    While his publications are excellent, showcasing patents, industry collaborations, or drug development pipelines would better demonstrate translational relevance.

  2. Global Outreach:
    Participation in international conferences, scientific boards, or as an editorial reviewer could enhance his global visibility.

  3. Public Engagement:
    Greater involvement in public science communication or outreach could boost his societal impact profile.

🎓 Education:

Dr. Minghe Luo earned his Doctorate in Pharmacy from Wuhan University (2018–2021), under the supervision of Prof. Yuhui Sun, focusing on the biosynthesis of natural products. Prior to this, he completed a Master’s degree in Medicinal Chemistry of Natural Products through a joint program between Southwest University and the South China Sea Institute of Oceanology (2008–2011), guided by Professors Zichuan Bai and Jianhua Ju. His postgraduate training emphasized the chemical characterization and bioactivity of marine-derived fungal metabolites. This unique blend of pharmacy and chemistry, alongside rigorous experimental research, laid the foundation for his expertise in microbial natural product discovery and biosynthesis. Dr. Luo’s academic development reflects a deep commitment to both theoretical understanding and applied research, equipping him with the tools to lead investigations into novel bioactive compounds, particularly those from extreme marine environments.

💼 Experience:

Dr. Luo began his career as a research scientist at the Third Affiliated Hospital of the Third Military Medical University (2011–2018), focusing on microbial natural product discovery. In 2021, he joined Chongqing University of Technology as an Associate Professor, where he leads independent projects on biosynthetic pathway elucidation and engineering of marine microbial metabolites. His role includes teaching pharmacy courses and mentoring graduate students. Dr. Luo’s experience spans isolation, structural elucidation, and genetic manipulation of microbial strains to unlock cryptic biosynthetic potential. His consistent publication record demonstrates both foundational research and innovative biosynthetic strategies. Over the years, he has cultivated a reputation for high-quality research and collaborative spirit, contributing significantly to antibiotic and anticancer compound discovery pipelines. He is particularly recognized for exploring deep-sea actinomycetes, making meaningful strides in developing novel antibacterial agents against drug-resistant pathogens.

🔬 Research Focus:

Dr. Luo’s research centers on the biosynthesis of microbial natural products, particularly from marine-derived actinomycetes and fungi. His primary interests include identifying novel polyketides, non-ribosomal peptides, and hybrid metabolites with antibacterial or anticancer potential. He employs genome mining, biosynthetic gene cluster (BGC) characterization, and pathway engineering to discover and optimize the production of bioactive compounds. A key theme in his work is understanding the mechanisms of tailoring enzymes (e.g., methyltransferases, P450s, dehydrating modules) that diversify natural product structures. Dr. Luo has also made major strides in elucidating biosynthetic pathways like those for hangtaimycin and streptovaricins. He is passionate about translating his findings into new drug leads, particularly targeting MRSA and multi-drug-resistant infections. His interdisciplinary approach bridges organic chemistry, synthetic biology, and pharmacology, contributing to the broader field of drug discovery from marine natural sources.

📚 Publications Top Notes:

  1. 🧪 The mechanism of dehydrating bimodules in trans-AT polyketide biosynthesis: hangtaimycin study – Angew. Chem. Int. Edit.

  2. 🧬 Methylation in hangtaimycin biosynthesis and its antibacterial activities – Synth. Syst. Biotechnol.

  3. 💊 Local delivery of deep marine equisetin via PVP nanofibers for anti-MRSA – Chem. Eng. J.

  4. 🌊 Natural siderophore acremonpeptides and their aluminum complex from Acremonium – J. Nat. Prod.

  5. 🔬 Amino acid-conjugated anthraquinones from marine Penicillium sp. – J. Nat. Prod.

  6. 🌐 Halogenated anthraquinones from Aspergillus sp. – J. Nat. Prod.

  7. 🧫 Genome-based mining of carpatamides I–M and their biosynthetic gene cluster – Mar. Drugs

  8. 🌿 Antibacterial lobophorin L and M from marine Streptomyces sp. – Nat. Prod. Res.

  9. 🧪 Two new streptovaricin derivatives from Streptomyces spectabilis mutants – Nat. Prod. Res.

  10. ⚗️ Mycophenolic acid derivative from Penicillium sp. fermentation – Nat. Prod. Res.

🧾 Conclusion:

Dr. Minghe Luo clearly exhibits the scientific rigor, innovation, and productivity deserving of the Best Researcher Award. His contributions to the field of natural product chemistry and biosynthesis, especially in the context of antimicrobial resistance, are both timely and impactful. With minor improvements in translational output and international visibility, he is poised to become a leading figure globally in pharmaceutical biotechnology.

Xingting Guo | Stem Cell Research | Best Researcher Award

Posted on by Cell Biologist

Assist. Prof. Dr. Xingting Guo | Stem Cell Research | Best Researcher Award

Assist. Prof. Dr. Xingting Guo , Peking University Third Hospital , China

Dr. Xingting Guo is a dedicated postdoctoral fellow at the National Institute of Biological Sciences (NIBS), Beijing, where she has been working since 2018. With a strong academic foundation in biochemistry and molecular biology, her research delves into stem cell biology, cellular differentiation, and tumorigenesis using Drosophila and mouse models. Her expertise lies in integrating genetics, biochemistry, single-cell sequencing, and bioinformatics to unravel mechanisms of cell fate specification and intestinal homeostasis. Dr. Guo has co-authored several high-impact publications and has presented her research at both national and international conferences. Her contributions have significantly advanced our understanding of enteroendocrine cells (EECs), tissue identity, and inter-organ communication. Passionate and detail-oriented, she is actively contributing to biomedical sciences with a vision to translate fundamental biology into therapeutic insights. Her work is paving the way for novel treatments for metabolic diseases and cancers.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Innovative Research Focus: Dr. Guo has made pioneering contributions in stem cell biology, particularly in understanding cell fate specification, enteroendocrine diversity, and tumor suppression using Drosophila and murine models.

  2. Multidisciplinary Skillset: She integrates genetics, high-throughput sequencing, bioinformatics, organoid culture, and in vivo models, showcasing deep technical expertise.

  3. High-Impact Publications: Co-first author in multiple peer-reviewed journals, including Cell Reports, Nature Communications, and FEBS Journal.

  4. Leadership in Research: From graduate researcher to postdoctoral fellow, she has led multiple independent projects, contributing novel findings to developmental and regenerative biology.

  5. International Recognition: Regular presenter at top-tier conferences globally, including the European Drosophila Research Conference and Annual Drosophila Research Conference (USA).

  6. Research Funding: Successfully secured National Natural Science Foundation of China funding, reflecting scientific merit and recognition.

🔍 Areas for Improvement:

  1. Broader Collaboration: Expanding collaborations outside her current institute or internationally may enhance the translational reach and impact of her research.

  2. Mentorship Roles: While her research is strong, formal mentorship roles (e.g., supervising Ph.D. students) or teaching contributions could further demonstrate leadership.

  3. Clinical Translation: Though her mouse model work touches on therapeutic discovery, publishing more translational or clinical-facing studies could boost her impact in applied biomedical research.

🎓 Education:

Dr. Xingting Guo earned her Ph.D. in Biochemistry and Molecular Biology from the College of Life Sciences at Beijing Normal University (2012–2018), where she began her in-depth research on stem cell biology and tissue differentiation in Drosophila. Prior to this, she completed her Bachelor’s degree in Biological Engineering at Nanjing Agricultural University (2008–2012), where she was honored with multiple scholarships for academic excellence. Throughout her education, she developed a robust foundation in molecular biology, genetics, and developmental biology, equipping her with the skills to tackle complex biological questions. Her academic journey has been characterized by continuous academic excellence, curiosity-driven research, and a commitment to uncovering the molecular mechanisms of health and disease. Her education laid the groundwork for her successful transition to cutting-edge postdoctoral research in developmental biology and regenerative medicine.

💼 Experience:

Dr. Guo began her research career at NIBS Beijing as a graduate student in 2012, transitioning into a postdoctoral fellow in 2018 under the mentorship of Dr. Rongwen Xi. Her research primarily uses Drosophila intestinal systems and murine models to explore the regulation of cellular identity, differentiation, and plasticity. She has led multiple projects on tumor suppression, transcriptional regulation, and enteroendocrine diversity using advanced techniques like genetic manipulation, single-cell RNA sequencing, and organoid cultures. Additionally, she contributes to translational research by identifying drug targets for diabetes-related therapy by reprogramming intestinal cells into insulin-producing β-cells. Her interdisciplinary approach and long-standing expertise in stem cell biology highlight her versatility and innovation in research. Her consistent progression from graduate student to independent researcher reflects her strong scientific rigor and leadership in high-impact studies.

🏆 Awards and Honors:

Dr. Xingting Guo has been recognized for her academic excellence and scientific contributions through numerous honors. During her Ph.D., she was awarded the First Class Academic Scholarship for two consecutive years (2014–2016). As an undergraduate, she earned the prestigious Cyrus Tang Scholarship four times, along with the First Class Scholarship at Nanjing Agricultural University. In recent years, she has taken on the role of a peer reviewer for Bio-protocols, highlighting her engagement with the scientific community. Dr. Guo’s research excellence has led her to represent her work at top-tier conferences, including the Annual Drosophila Research Conference (USA) and the European Drosophila Research Conference (Switzerland). Her contributions were also supported by a grant from the National Natural Science Foundation of China (Grant No. 3210050518), demonstrating her ability to secure competitive funding. These accolades mark her as a rising star in molecular and developmental biology.

🔬 Research Focus:

Dr. Guo’s research focuses on the molecular regulation of stem cell differentiation, cellular identity maintenance, and neuroendocrine cell plasticity using Drosophila and mouse models. She investigates how transcription factors such as ttk69 influence enteroendocrine (EEC) specification, tissue homeostasis, and tumor suppression. Using cutting-edge tools like CRISPR, single-cell transcriptomics, and in vivo lineage tracing, she deciphers how intestinal stem cells differentiate into diverse terminal cell types. Her recent work explores how intestinal EECs regulate systemic physiology via neuropeptides in response to environmental cues like starvation and mating. In parallel, she studies cell-fate reprogramming in mammals to identify potential therapeutic strategies for diabetes by inducing insulin-producing cells in the gut. By bridging basic biology with translational goals, her work contributes to regenerative medicine, oncology, and metabolic disease research.

📚 Publications Top Notes:

  • 🧠 Cell-fate conversion of intestinal cells in adult Drosophila midgut by depleting a single transcription factor, Nature Communications, 2024

  • 🔍 The Specification and Function of Enteroendocrine Cells in Drosophila and Mammals: A Comparative Review, FEBS Journal, 2021

  • 🧬 A Switch in Tissue Stem Cell Identity Causes Neuroendocrine Tumors in Drosophila Gut, Cell Reports, 2020

  • 🧫 The Cellular Diversity and Transcription Factor Code of Drosophila Enteroendocrine Cells, Cell Reports, 2019

  • 🧬 Division of Labor: Roles of Groucho and CtBP in Notch-Mediated Lateral Inhibition, Stem Cell Reports, 2019

  • 📘 Signaling Pathways Regulating Stem Cells, Book Chapter, Springer, 2015

  • 🛑 Ttk69 acts as a master repressor of enteroendocrine cell specification, Development, 2015

  • 🧪 EGFR and Notch signaling regulate gastric stem cells, Cell Research, 2014

  • 🧠 Sox9 Ortholog Regulates Intestinal Homeostasis and Regeneration in Drosophila, Cell Reports, 2020

🧾 Conclusion:

Dr. Xingting Guo is a highly qualified and deserving candidate for the Best Researcher Award. Her exceptional track record in stem cell biology, cellular reprogramming, and disease modeling makes her a rising star in the life sciences. With a unique combination of technical excellence, scientific innovation, and publication strength, she has already made a significant impact on our understanding of intestinal cell biology and endocrine regulation. Addressing a few career development aspects—like expanding collaborative networks and clinical translation—will make her an even more formidable leader in the field. Given her achievements, potential, and contributions, she is strongly recommended for this prestigious honor.